Invitrogen™ Silencer™ Human Drug Targets siRNA Library (96 well)

Invitrogen™ Silencer™ Human Drug Targets siRNA Library (96 well)

The Silencer™ Human Drug Targets siRNA Library includes genes involved in apoptosis, senescence, nucleic acid binding, autophagy, DNA repair, and along with characterized nuclear receptors and other genes that are considered potential targets for therapeutics. The Silencer Human Drug Targets siRNA Library contains 23,745 Ambion™ Silencer siRNAs targeting 7,915 genes for performing RNAi screens against known human drug target genes. The library was designed using the most up-to-date genome databases, including the NCBI RefSeq database and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC). Utilizing Ambion Silencer technology built on stringent bioinformatics to enable high target specificity and siRNA potency, the Silencer Human Drug Targets siRNA Library is an ideal solution for focused and cost-effective RNAi screening against pre-defined therapeutic gene drug targets .

Features

• Comprehensive—Expedite functional gene discovery with pre-defined Ambion Silencer Human Druggable siRNA Library
• Reliable—Increase target screening accuracy with three individual siRNAs per gene target.
• Effective—Reduce off target impacts at low concentrations with our proven Ambion Silencer siRNA design
• Convenient—Reduce data de-convolution and accelerate target validation with our 96- or 384-well arrayed format
• Customizable—Choose the best option available to meet your workflow demands, including additional siRNA scales and pooled formats

Contents

• 23,745 total siRNAs targeting 7915 genes plated onto 96-well plates ( 270 plates)